The Dutch LimFlow registry; a clinical post marketing trial investigating the long term results after a Percutaneous Deep Vein Arterialization (LimFlow) in the treatment of no-option chronic limb threatening ischemia patient.

Dutch LimFlow Registry

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21714

Enrollment

Registered

2019-11-13

Start date

2020-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic limb threatening ischemia

Interventions

Percutaneous deep venous arterialization

Eligibility

Inclusion criteria

Inclusion criteria: I-1. Approved for the LimFlow procedure I-2. Subject is willing and has adequate support to comply with protocol requirements, including medication regimen and followup visits

Exclusion criteria

Exclusion criteria: E-1. Patient unable to give consent

Design outcomes

Primary

Measure	Time frame
Amputation-free survival at 24 months follow-up	—

Secondary

Measure	Time frame
Secondary objectives are to evaluate the long-term effect of pDVA on: - Complete wound healing - Primary and secondary patency - Limb salvage - Renal function - Quality of life - Long term cardial effect - Cost effectiveness	—

Contacts

Public ContactEline Huizing

Northwest Clinics

e.huizing@nwz.nl072 548 4444

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)